Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension
- 9 December 2019
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 79 (3), 370-378
- https://doi.org/10.1136/annrheumdis-2019-216476
Abstract
Background In this study, we investigated the impact of the new haemodynamic definition of pulmonary arterial hypertension (PAH) as proposed by the 6th PH World Symposium on phenotypes and survival in patients with systemic sclerosis (SSc). Methods In SSc patients who were prospectively and consecutively screened for PAH including right heart catheterisation in Heidelberg or Zurich, haemodynamic and clinical variables have been reassessed according to the new PAH definition. Patients have been followed for 3.7±3.7 (median 3.4) years; Kaplan-Meier survival analysis was performed. Patients with significant lung or left heart disease were excluded from comparative analyses. Results The final dataset included 284 SSc patients, 146 patients (49.2%) had mean pulmonary arterial pressure (mPAP) ≤20 mm Hg, 19.3% had mPAP 21–24 mm Hg and 29.4% had mPAP ≥25 mm Hg. In the group of mildly elevated mPAP, only four patients (1.4% of the whole SSc cohort) had pulmonary vascular resistance (PVR) values ≥3 Wood Units (WU) and could be reclassified as manifest SSc-APAH. Twenty-eight (9.8%) patients with mPAP of 21–24 mm Hg and PVR ≥2 WU already presented with early pulmonary vascular disease with decreased 6 min walking distance (6MWD) (pConclusion The data of this study show that a PVR threshold ≥3 WU is too high to enable an early diagnosis of PAH. A PVR threshold ≥2 WU was already associated with pulmonary vascular disease, significantly reduced survival and would be more appropriate in SSc patients with mild PAH.Keywords
This publication has 32 references indexed in Scilit:
- Survival and Prognostic Factors in Systemic Sclerosis–Associated Pulmonary Hypertension: A Systematic Review and Meta‐AnalysisArthritis & Rheumatism, 2013
- Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT studyAnnals Of The Rheumatic Diseases, 2013
- Pulmonary arterial hypertension therapy may be safe and effective in patients with systemic sclerosis and borderline pulmonary artery pressureArthritis & Rheumatism, 2012
- Pulmonary vascular resistances during exercise in normal subjects: a systematic reviewEuropean Respiratory Journal, 2011
- Screening for pulmonary arterial hypertension in patients with systemic sclerosis: Clinical characteristics at diagnosis and long‐term survivalArthritis & Rheumatism, 2011
- Pulmonary arterial hypertension associated with systemic sclerosisExpert Review of Respiratory Medicine, 2011
- Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic reviewEuropean Respiratory Journal, 2009
- Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment EraAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter studyArthritis & Rheumatism, 2005
- Pulmonary hypertension in systemic sclerosis: an analysis of 17 patientsRheumatology, 1996